Products for assisted reproduction

Vitrolife

Vitrolife is a Swedish medtech company focused on developing, manufacturing and marketing products used in In Vitro Fertilsation (IVF). Vitrolife offers its customers a wide range of products and solutions, including culture media, disposable products and capital equipment products. Vitrolife is a global company, with sales in some 110 countries.

Financials

Vitrolife

SEKm 2018 2019 2020
Sales 1133 1337 1444
Sales growth (%) 8,3 18 8
EBITDA 461 523 N/A
EBITDA margin (%) 38,9 40,7 39,1
EBIT adj 341 393 440
EBIT adj margin (%) 32,6 34,7 32,9
Pretax profit 393 442 486
EPS rep 2,82 3,16 3,47
EPS growth (%) 15,6 12,1 9,9
EPS adj 3,11 3,45 3,76
DPS 1 1 1
EV/EBITDA (x) 35,9 31,2 28,2
EV/EBIT adj (x) 42,2 37 33,1
P/E (x) 55,6 49,6 45,1
P/E adj (x) 50,4 45,5 41,7
EV/sales (x) 14,6 12,2 11,1
FCF yield (%) 1 2,2 2,4
Dividend yield (%) 0,6 0,6 0,6
Net IB debt/EBITDA -0,9 -1,3 -1,8

Main shareholders

Vitrolife

Main shareholders Share capital % Voting shares % Verified
William Demant Invest A/S 22.6 % 22.6 % 31 Dec 2018
Bure Equity 20.8 % 20.8 % 31 Dec 2018
Capital Group 4.6 % 4.6 % 31 Dec 2018
Lannebo Fonder 3.1 % 3.1 % 30 Nov 2018
Morgan Stanley Investment Management 2.5 % 2.5 % 30 Sep 2018
Eccenovo AB 2.1 % 2.1 % 31 Dec 2018
Norges Bank 2.0 % 2.0 % 31 Dec 2018
Vanguard 1.6 % 1.6 % 31 Dec 2018
La Financière de l'Echiquier 1.2 % 1.2 % 30 Sep 2018
GLG Partners 1.1 % 1.1 % 30 Nov 2018
Source: Holdings by Modular Finance AB

Insider list

Vitrolife

Name
Mikael Engblom
Barbro Fridén
Thomas Axelsson
Mikael Engblom
Mikael Engblom
Mikael Engblom
Mikael Engblom
Helena Engblom
Mikael Engblom
Thomas Axelsson
Show More